{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P10632",
      "entity_text" : "CYP2C8",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P37231",
      "entity_text" : "PPARgamma",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Moreover, the PPARgamma specific inhibitor GW9662 partially eliminated the beneficial effects of CYP2C8 transfection or the exogenous supply with 11,12-EET.",
  "reading_complete" : "2020-08-02T09:37:27Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T09:36:12Z",
  "trigger" : "eliminated",
  "evidence" : [ "PPARgamma-specific inhibitor GW9662 partially eliminated the beneficial effects of CYP2C8" ],
  "pmc_id" : "4121355",
  "score" : 0
}